## **Core Concept**
SRS-A, or Slow-reacting substance of anaphylaxis, refers to a group of cysteinyl leukotrienes that play a crucial role in the pathophysiology of allergic reactions, particularly in asthma and anaphylaxis. These substances are produced by the action of lipoxygenase on arachidonic acid. They cause smooth muscle contraction, increased vascular permeability, and mucus production.

## **Why the Correct Answer is Right**
The correct answer, Leukotriene C4, D4, and E4, are indeed the components of SRS-A. These cysteinyl leukotrienes (LTC4, LTD4, LTE4) are potent bronchoconstrictors and are key mediators in the inflammatory process of asthma. They are formed from the metabolism of arachidonic acid through the 5-lipoxygenase pathway. Their actions include inducing bronchospasm, increasing mucus secretion, and enhancing vascular permeability, which are critical in the development of symptoms during allergic reactions.

## **Why Each Wrong Option is Incorrect**
- **Option A:** This option is blank and does not provide any information to evaluate.
- **Option B:** This option is also blank and cannot be assessed.
- **Option C:** Similarly, this option does not contain any relevant information.
- **Option D:** This option is also blank.

## **Clinical Pearl / High-Yield Fact**
A key clinical pearl is that cysteinyl leukotriene receptor antagonists (e.g., montelukast) are effective in the management of asthma and work by blocking the action of LTC4, LTD4, and LTE4. This highlights the importance of understanding the role of SRS-A (cysteinyl leukotrienes) in allergic reactions and asthma.

## **Correct Answer:** . Leukotriene C4, D4, and E4